132 related articles for article (PubMed ID: 9923800)
1. Computerized nuclear morphometry: a new morphologic assessment for advanced gastric adenocarcinoma.
Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Ann Surg; 1999 Jan; 229(1):55-61. PubMed ID: 9923800
[TBL] [Abstract][Full Text] [Related]
2. Computerized nuclear morphometry is a useful technique for evaluating the high metastatic potential of colorectal adenocarcinoma.
Ikeguchi M; Sakatani T; Endo K; Makino M; Kaibara N
Cancer; 1999 Nov; 86(10):1944-51. PubMed ID: 10570417
[TBL] [Abstract][Full Text] [Related]
3. Nuclear accumulation of p53 protein in gastric cancer strongly correlates with enlargement of nuclear area of cancer cells.
Ikeguchi M; Oka S; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Oncol Rep; 2000; 7(3):579-84. PubMed ID: 10767371
[TBL] [Abstract][Full Text] [Related]
4. Nuclear profiles of cancer cells reveal the metastatic potential of gastric cancer.
Ikeguchi M; Cai J; Oka S; Gomyou Y; Tsujitani S; Maeta M; Kaibara N
J Pathol; 2000 Sep; 192(1):19-25. PubMed ID: 10951395
[TBL] [Abstract][Full Text] [Related]
5. Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity.
Ikeguchi M; Sato N; Hirooka Y; Kaibara N
J Surg Oncol; 1998 Aug; 68(4):225-30. PubMed ID: 9721707
[TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
7. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
9. Nuclear morphometry as a predictor of disease outcome in gastric cancer.
Setälä L; Lipponen P; Kosma VM; Marin S; Eskelinen M; Syrjänen K; Alhava E
J Pathol; 1997 Jan; 181(1):46-50. PubMed ID: 9072002
[TBL] [Abstract][Full Text] [Related]
10. Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma.
Ikeguchi M; Taniguchi T; Makino M; Kaibara N
Scand J Gastroenterol; 2000 Aug; 35(8):839-46. PubMed ID: 10994623
[TBL] [Abstract][Full Text] [Related]
11. Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma.
Nakashima Y; Yao T; Hirahashi M; Aishima S; Kakeji Y; Maehara Y; Tsuneyoshi M
Histopathology; 2011 Nov; 59(5):841-9. PubMed ID: 22092395
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
13. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
Fujimoto D; Goi T; Hirono Y
Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352
[TBL] [Abstract][Full Text] [Related]
14. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
16. Correlation of 15-prostagladin dehydrogenase expression with clinicopathological factors and survival rate in gastric adenocarcinoma.
Seo SH; Kang MS; Kim KH; An MS; Ha TK; Bae KB; Oh MK; Choi CS; Oh SH; Choi YK
Int J Surg; 2015 Jan; 13():96-101. PubMed ID: 25704623
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
18. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Oro S; Tatebe S; Tsujitani S; Ikeguchi M
Am J Surg; 2006 Sep; 192(3):296-300. PubMed ID: 16920421
[TBL] [Abstract][Full Text] [Related]
19. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
20. Nuclear shape, architecture and orientation features from H&E images are able to predict recurrence in node-negative gastric adenocarcinoma.
Ji MY; Yuan L; Jiang XD; Zeng Z; Zhan N; Huang PX; Lu C; Dong WG
J Transl Med; 2019 Mar; 17(1):92. PubMed ID: 30885234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
